Ortivus AB (publ) interim report for the period January – March 2023

Ortivus initiates customer delivery projects in the Baltics

Highlights January – March 2023

  • Ortivus signs a framework agreement with East of England NHS Collaborative Procurement Hub regarding MobiMed ePR, creating new opportunities in the UK. The agreement means that all UK Ambulance Trusts can call-off electronic patient records – ePR solutions, from all qualified companies. The contract period is 2 years from the start date.
  • Ortivus signs a contract regarding the delivery of MobiMed ePR to the Estonian ambulance fleet. The contract has an order value of approximately 26 MSEK over a period of 5 years with a possible extension for another 5 years. The extension period also has an estimated order value of 26 MSEK.
  • Ortivus signs a framework agreement with Stockholm County Healthcare District (SLSO) regarding MobiMed Life, semi-automatic defibrillators. The customer will call-off units as need arises. The total order value for the entire framework agreement period, which is four years, amounts to a maximum of 2.4 MSEK.
  • Ortivus AB acquires approx. 10% of the company H&E Solutions AB, a Swedish technology company that has developed Evam – an operating system for emergency vehicles.

Significant events after end of the period

  • Ortivus qualifies for the NHS framework agreement covering MobiMed Life, which creates new opportunities in the UK.
  • Ortivus’ product range is further broadened via an asset purchase agreement of the vehicle control system FleetCtrl, which together with Ortivus’ other products form a competitive total solution for the future of healthcare.

January – march 2023

  • Net sales amounted to 28.0 (24.6) MSEK.
  • The gross margin amounted to 48% (47%).
  • EBITDA amounted to 0.2 (2.0) MSEK.
  • Earnings after tax per share before and after dilution amounted to 0.01 (0.04) SEK.
  • Operating cash flow before changes in working capital amounted to 1.5 (2.4) MSEK.
Jan-Mar 2023 Jan-Mar 2022 Jan-Dec 2022
Net sales (MSEK) 28.0 24.6 104.5
Gross margin (%) 48% 47% 47%
Operating profit (MSEK) 0.5 2.0 5.8
Operating margin (%) 2% 8% 6%
EBITDA (MSEK) 1.5 2.9 10.2
This entry was posted in . Bookmark the permalink.